One retrospective analysis of 993 intraindividual tissue samples from primary breast tumors and relapses found alterations in estrogen receptor (ER), progesterone receptor (PR), and HER2 status in 32%, 41%, and 15% of patients, respectively [15]. The gene discussed is ESR1; the disease is breast neoplasm.